-
Intraductal papilloma of the breast: Short-review
Shinya Tajima, Ichiro Maeda, Keiko Kishimoto, Saeko Naruki, Akira Endo, Masatomo Doi, Motohiro Chosokabe, Koichiro Tsugawa, Masayuki Takagi, Junki Koike
Mini Review: Clinical Investigation
-
Intraductal papilloma of the breast: Short-review
Shinya Tajima, Ichiro Maeda, Keiko Kishimoto, Saeko Naruki, Akira Endo, Masatomo Doi, Motohiro Chosokabe, Koichiro Tsugawa, Masayuki Takagi, Junki Koike
Mini Review: Clinical Investigation
-
Intraductal papilloma of the breast: Short-review
Shinya Tajima, Ichiro Maeda, Keiko Kishimoto, Saeko Naruki, Akira Endo, Masatomo Doi, Motohiro Chosokabe, Koichiro Tsugawa, Masayuki Takagi, Junki Koike
Mini Review: Clinical Investigation
-
Intraductal papilloma of the breast: Short-review
Shinya Tajima, Ichiro Maeda, Keiko Kishimoto, Saeko Naruki, Akira Endo, Masatomo Doi, Motohiro Chosokabe, Koichiro Tsugawa, Masayuki Takagi, Junki Koike
Mini Review: Clinical Investigation
-
Intraductal papilloma of the breast: Short-review
Shinya Tajima, Ichiro Maeda, Keiko Kishimoto, Saeko Naruki, Akira Endo, Masatomo Doi, Motohiro Chosokabe, Koichiro Tsugawa, Masayuki Takagi, Junki Koike
Mini Review: Clinical Investigation
-
Intraductal papilloma of the breast: Short-review
Shinya Tajima, Ichiro Maeda, Keiko Kishimoto, Saeko Naruki, Akira Endo, Masatomo Doi, Motohiro Chosokabe, Koichiro Tsugawa, Masayuki Takagi, Junki Koike
Mini Review: Clinical Investigation
-
Intraductal papilloma of the breast: Short-review
Shinya Tajima, Ichiro Maeda, Keiko Kishimoto, Saeko Naruki, Akira Endo, Masatomo Doi, Motohiro Chosokabe, Koichiro Tsugawa, Masayuki Takagi, Junki Koike
Mini Review: Clinical Investigation
-
Intraductal papilloma of the breast: Short-review
Shinya Tajima, Ichiro Maeda, Keiko Kishimoto, Saeko Naruki, Akira Endo, Masatomo Doi, Motohiro Chosokabe, Koichiro Tsugawa, Masayuki Takagi, Junki Koike
Mini Review: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
Core outcomes in vitiligo trials: progress and challenges
V Eleftheriadou, KS Thomas, JM Batchelor, JC Ravenscroft, ME Whitton
Editorial: Clinical Investigation
-
Core outcomes in vitiligo trials: progress and challenges
V Eleftheriadou, KS Thomas, JM Batchelor, JC Ravenscroft, ME Whitton
Editorial: Clinical Investigation
-
Core outcomes in vitiligo trials: progress and challenges
V Eleftheriadou, KS Thomas, JM Batchelor, JC Ravenscroft, ME Whitton
Editorial: Clinical Investigation
-
Core outcomes in vitiligo trials: progress and challenges
V Eleftheriadou, KS Thomas, JM Batchelor, JC Ravenscroft, ME Whitton
Editorial: Clinical Investigation
-
Core outcomes in vitiligo trials: progress and challenges
V Eleftheriadou, KS Thomas, JM Batchelor, JC Ravenscroft, ME Whitton
Editorial: Clinical Investigation
-
Core outcomes in vitiligo trials: progress and challenges
V Eleftheriadou, KS Thomas, JM Batchelor, JC Ravenscroft, ME Whitton
Editorial: Clinical Investigation
-
Core outcomes in vitiligo trials: progress and challenges
V Eleftheriadou, KS Thomas, JM Batchelor, JC Ravenscroft, ME Whitton
Editorial: Clinical Investigation
-
Core outcomes in vitiligo trials: progress and challenges
V Eleftheriadou, KS Thomas, JM Batchelor, JC Ravenscroft, ME Whitton
Editorial: Clinical Investigation
-
International investigator-driven clinical trials: challenges and opportunities for US - Europe cooperation through the US cooperative group networks
Denis Lacombe, Anastassia Negrouk, John Bean
Clinical Trail Outcomes: Clinical Investigation
-
International investigator-driven clinical trials: challenges and opportunities for US - Europe cooperation through the US cooperative group networks
Denis Lacombe, Anastassia Negrouk, John Bean
Clinical Trail Outcomes: Clinical Investigation
-
International investigator-driven clinical trials: challenges and opportunities for US - Europe cooperation through the US cooperative group networks
Denis Lacombe, Anastassia Negrouk, John Bean
Clinical Trail Outcomes: Clinical Investigation
-
International investigator-driven clinical trials: challenges and opportunities for US - Europe cooperation through the US cooperative group networks
Denis Lacombe, Anastassia Negrouk, John Bean
Clinical Trail Outcomes: Clinical Investigation
-
International investigator-driven clinical trials: challenges and opportunities for US - Europe cooperation through the US cooperative group networks
Denis Lacombe, Anastassia Negrouk, John Bean
Clinical Trail Outcomes: Clinical Investigation
-
International investigator-driven clinical trials: challenges and opportunities for US - Europe cooperation through the US cooperative group networks
Denis Lacombe, Anastassia Negrouk, John Bean
Clinical Trail Outcomes: Clinical Investigation
-
International investigator-driven clinical trials: challenges and opportunities for US - Europe cooperation through the US cooperative group networks
Denis Lacombe, Anastassia Negrouk, John Bean
Clinical Trail Outcomes: Clinical Investigation
-
International investigator-driven clinical trials: challenges and opportunities for US - Europe cooperation through the US cooperative group networks
Denis Lacombe, Anastassia Negrouk, John Bean
Clinical Trail Outcomes: Clinical Investigation